Intelligent Bio Solutions Long Term Debt 2020-2025 | INBS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Intelligent Bio Solutions long term debt from 2020 to 2025. Long term debt can be defined as the sum of all long term debt fields.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Intelligent Bio Solutions long term debt from 2020 to 2025. Long term debt can be defined as the sum of all long term debt fields.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$151.9B
CVS Health (CVS)	$90B
Elevance Health (ELV)	$70.3B
Cencora (COR)	$57.1B
DiDi Global (DIDIY)	$27.2B
Labcorp Holdings (LH)	$22.9B
Natera (NTRA)	$22B
BioMerieux (BMXMF)	$18B
EUROFINS SCIENT (ERFSF)	$15.5B
ICON (ICLR)	$14.5B
Medpace Holdings (MEDP)	$13B
CochLear (CHEOY)	$12.6B
Solventum (SOLV)	$12.5B
Viatris (VTRS)	$12.5B
Revvity (RVTY)	$10.6B
Caris Life Sciences,�Inc (CAI)	$10.4B
Sonic Healthcare (SKHHY)	$9.3B
Avantor (AVTR)	$8.8B
Charles River Laboratories (CRL)	$7.8B
HealthEquity (HQY)	$7.8B
Bausch + Lomb (BLCO)	$5.2B
Sotera Health (SHC)	$4.6B
BrightSpring Health Services (BTSG)	$4.1B
Amplifon S.p.A (AMFPF)	$3.9B
GeneDx Holdings (WGS)	$3.5B
Surgery Partners (SGRY)	$3B
Alignment Healthcare (ALHC)	$3B
Concentras Parent (CON)	$2.9B
Organon (OGN)	$2.4B
Premier (PINC)	$2.2B